指南与共识消化道肿瘤与早癌消化内镜

囊性纤维化结直肠癌筛查共识推荐

Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations.
指南 / 共识 · Gastroenterology · 2017-12-29

囊性纤维化(CF)成人结直肠癌(CRC)风险为一般人群的5-10倍,器官移植后为25-30倍。CF基金会召集18人工作组制定10条筛查推荐,强调共同个体化决策,推荐结肠镜为首选方法、40岁起始筛查、5年复筛和3年监测间隔及CF特异性强化肠道准备。

要点

  • 推荐结肠镜作为CF成人CRC筛查的首选方法。
  • 推荐CF成人从40岁开始CRC筛查,每5年复筛,监测间隔3年(除非个体发现提示更短间隔)。
  • CF器官移植受者应在移植后2年内、30岁开始CRC筛查。

核心结论

  • 工作组提出10条CF成人CRC筛查推荐,强调共同个体化决策并熟悉CF特异性胃肠道挑战。

研究设计与样本

  • CF基金会召集18人 multi-stakeholder 工作组,含肺科、消化科、社工、护士协调员、外科、流行病学、统计、CF成人和家长。
  • 工作组设癌症风险、移植、操作与准备3个工作组;指南专家2016年2-3月基于PubMed检索进行证据合成,共检索1159篇,全文阅读198篇,分析123篇形成推荐。
  • 荷兰Erasmus医学中心公共卫生部用癌症干预与监测建模网络微模拟筛查分析模型进行独立决策分析;推荐声明需达80%接受阈值才纳入最终指南。

主要发现

  • CF成人CRC风险为一般人群的5-10倍,器官移植后CF患者为25-30倍。
  • 工作组提出10条CRC筛查推荐,强调共同、个体化决策和熟悉CF特异性胃肠道挑战。

关键数值与推荐

  • 推荐结肠镜作为首选筛查方法。
  • 推荐从40岁开始筛查,5年复筛和3年监测间隔(除非个体发现提示更短间隔)。
  • 推荐CF特异性强化肠道准备。
  • CF器官移植受者因免疫抑制相关额外结肠癌风险,应在移植后2年内、30岁开始CRC筛查。
  • 推荐声明需达80%接受阈值才纳入最终指南。

临床怎么用

  • 推荐用于帮助CF成人、家庭、初级保健医生、消化科医生及CF和移植中心处理CRC筛查问题。
  • 推荐与一般人群指南在筛查起始年龄、筛查方法、准备及重复筛查和监测间隔方面不同。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Improved therapy has substantially increased survival of persons with cystic fibrosis (CF). But the risk of colorectal cancer (CRC) in adults with CF is 5-10 times greater compared to the general population, and 25-30 times greater in CF patients after an organ transplantation. To address this risk, the CF Foundation convened a multi-stakeholder task force to develop CRC screening recommendations. METHODS: The 18-member task force consisted of experts including pulmonologists, gastroenterologists, a social worker, nurse coordinator, surgeon, epidemiologist, statistician, CF adult, and a parent. The committee comprised 3 workgroups: Cancer Risk, Transplant, and Procedure and Preparation. A guidelines specialist at the CF Foundation conducted an evidence synthesis February-March 2016 based on PubMed literature searches. Task force members conducted additional independent searches. A total of 1159 articles were retrieved. After initial screening, the committee read 198 articles in full and analyzed 123 articles to develop recommendation statements. An independent decision analysis evaluating the benefits of screening relative to harms and resources required was conducted by the Department of Public Health at Erasmus Medical Center, Netherlands using the Microsimulation Screening Analysis model from the Cancer Innervation and Surveillance Modeling Network. The task force included recommendation statements in the final guideline only if they reached an 80% acceptance threshold. RESULTS: The task force makes 10 CRC screening recommendations that emphasize shared, individualized decision-making and familiarity with CF-specific gastrointestinal challenges. We recommend colonoscopy as the preferred screening method, initiation of screening at age 40 years, 5-year re-screening and 3-year surveillance intervals (unless shorter interval is indicated by individual findings), and a CF-specific intensive bowel preparation. Organ transplant recipients with CF should initiate CRC screening at age 30 years within 2 years of the transplantation because of the additional risk for colon cancer associated with immunosuppression. CONCLUSIONS: These recommendations aim to help CF adults, families, primary care physicians, gastroenterologists, and CF and transplantation centers address the issue of CRC screening. They differ from guidelines developed for the general population with respect to the recommended age of screening initiation, screening method, preparation, and the interval for repeat screening and surveillance.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hadjiliadis D, Khoruts A, Zauber AG, et al. Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations. Gastroenterology. 2017. PMID: 29289528. doi:10.1053/j.gastro.2017.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。